|
|||||
A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury. . . . → Read More: NIH Grant Funds New Spinal Cord Injury Treatment 
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods. . . . → Read More: Engineered Polio Virus Tested as Brain Cancer Treatment  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, cancer, clinical trials, entrepreneurs, licensing, life sciences, NIH, pharmaceuticals, university 
A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight. . . . → Read More: Univ. Spin-Off Developing Long-Lasting Diabetes Drug One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, grant, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, grant, investment, life sciences, NIH, pharmaceuticals, preclinical, university 
The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, genomics, life sciences, NIH, pharmaceuticals, preclinical 
A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases Comments are closed New products Africa, biomedical, biotechnology, genomics, life sciences, NIH, pharmaceuticals, preclinical 
A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care One comment - (Comments are closed) New products biomedical, cancer, engineering, Europe, genomics, life sciences, mathematics, medical device, NIH, pharmaceuticals, physical sciences, software 
An enterprise developing a synthetic antibody to treat breast cancer, spun-off from a University at Buffalo research lab, is taking part in a federal program to advance the treatments to clinical trials. . . . → Read More: Univ. Spinoff Qualifies for NIH Clinical Program Comments are closed New products biomedical, biotechnology, cancer, clinical trials, entrepreneurs, licensing, life sciences, NIH, pharmaceuticals, university 
A clinical trial is recruiting participants to test a vaccine to protect against a variety of influenza strains, instead of today’s vaccines designed to prevent infections from specific strains expected in a given year. . . . → Read More: Trial Underway Testing Universal Flu Vaccine Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, health care, Israel, life sciences, NIH, pharmaceuticals, university 
An analysis of the impact of proposed cuts in funds for research and development on technologies to address global health needs shows the U.S. economy benefits directly from this spending, including support of many jobs in nearly all states. . . . → Read More: Global Health R&D Cuts Threaten U.S. Economy, Jobs One comment - (Comments are closed) Business conditions biomedical, economics, health care, life sciences, NIH, statistics |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
